 Vitaly Kheyfets
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 14 | 2023 | 1736 | 2.410 |
Why?
| | Pulmonary Artery | 16 | 2023 | 1028 | 2.410 |
Why?
| | Ventricular Dysfunction, Right | 7 | 2023 | 218 | 1.930 |
Why?
| | Computer Simulation | 9 | 2020 | 880 | 1.500 |
Why?
| | Magnetic Resonance Imaging, Cine | 9 | 2021 | 175 | 1.340 |
Why?
| | Ventricular Function, Right | 11 | 2023 | 252 | 1.320 |
Why?
| | Pulmonary Circulation | 6 | 2022 | 407 | 1.310 |
Why?
| | Heart Ventricles | 9 | 2023 | 714 | 1.240 |
Why?
| | Vascular Resistance | 4 | 2022 | 337 | 1.230 |
Why?
| | Models, Cardiovascular | 5 | 2019 | 179 | 0.860 |
Why?
| | Regional Blood Flow | 5 | 2021 | 428 | 0.800 |
Why?
| | Pulmonary Embolism | 1 | 2023 | 184 | 0.740 |
Why?
| | Hemodynamics | 6 | 2022 | 1017 | 0.720 |
Why?
| | Ventilators, Mechanical | 1 | 2020 | 52 | 0.700 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 68 | 0.700 |
Why?
| | Fibrosis | 3 | 2021 | 454 | 0.670 |
Why?
| | Magnetic Resonance Angiography | 3 | 2017 | 236 | 0.620 |
Why?
| | Patient-Specific Modeling | 2 | 2017 | 36 | 0.590 |
Why?
| | Algorithms | 5 | 2020 | 1488 | 0.580 |
Why?
| | Hydrodynamics | 3 | 2018 | 37 | 0.580 |
Why?
| | Stress, Mechanical | 4 | 2019 | 447 | 0.510 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.500 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.500 |
Why?
| | Bandages | 1 | 2014 | 31 | 0.470 |
Why?
| | Arterial Pressure | 4 | 2020 | 99 | 0.450 |
Why?
| | Patients | 1 | 2015 | 162 | 0.440 |
Why?
| | Blood Flow Velocity | 5 | 2019 | 390 | 0.440 |
Why?
| | Gravitation | 1 | 2013 | 20 | 0.440 |
Why?
| | Cellulose | 1 | 2013 | 57 | 0.430 |
Why?
| | Materials Testing | 1 | 2014 | 339 | 0.420 |
Why?
| | Stroke Volume | 7 | 2022 | 510 | 0.410 |
Why?
| | Drug Carriers | 1 | 2013 | 112 | 0.410 |
Why?
| | Hypertension | 1 | 2020 | 1058 | 0.400 |
Why?
| | Wound Healing | 1 | 2014 | 259 | 0.400 |
Why?
| | Ventricular Remodeling | 3 | 2023 | 227 | 0.390 |
Why?
| | MicroRNAs | 1 | 2017 | 603 | 0.380 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2329 | 0.370 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 225 | 0.360 |
Why?
| | Polymers | 1 | 2014 | 447 | 0.360 |
Why?
| | Cardiac Catheterization | 6 | 2021 | 535 | 0.360 |
Why?
| | Biomarkers | 2 | 2023 | 3419 | 0.310 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2018 | 241 | 0.280 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3545 | 0.250 |
Why?
| | Vascular Stiffness | 4 | 2017 | 408 | 0.250 |
Why?
| | Humans | 32 | 2023 | 115042 | 0.250 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 141 | 0.220 |
Why?
| | Animals | 9 | 2023 | 31867 | 0.220 |
Why?
| | Blood Pressure | 2 | 2021 | 1539 | 0.210 |
Why?
| | Child | 11 | 2021 | 18407 | 0.210 |
Why?
| | Lung | 2 | 2022 | 3595 | 0.200 |
Why?
| | Hypoxia | 3 | 2023 | 958 | 0.200 |
Why?
| | Male | 18 | 2022 | 55731 | 0.200 |
Why?
| | Perfusion Imaging | 2 | 2019 | 52 | 0.200 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2021 | 48 | 0.190 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 1812 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2021 | 132 | 0.180 |
Why?
| | Tacrolimus | 1 | 2021 | 135 | 0.180 |
Why?
| | Proof of Concept Study | 1 | 2020 | 44 | 0.180 |
Why?
| | Ventricular Pressure | 1 | 2020 | 37 | 0.180 |
Why?
| | Respiratory Mechanics | 1 | 2020 | 57 | 0.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 928 | 0.180 |
Why?
| | Cardiac Output | 2 | 2017 | 143 | 0.170 |
Why?
| | Forecasting | 1 | 2021 | 332 | 0.170 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 469 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2021 | 698 | 0.170 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 273 | 0.160 |
Why?
| | Female | 16 | 2022 | 59613 | 0.160 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 1715 | 0.160 |
Why?
| | Alzheimer Disease | 1 | 2023 | 436 | 0.150 |
Why?
| | Mice | 4 | 2022 | 14927 | 0.150 |
Why?
| | Thermodilution | 1 | 2017 | 12 | 0.150 |
Why?
| | Transcriptome | 1 | 2023 | 725 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 63 | 0.150 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 92 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 253 | 0.140 |
Why?
| | Prospective Studies | 5 | 2021 | 6232 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1523 | 0.140 |
Why?
| | Lung Diseases | 1 | 2023 | 703 | 0.130 |
Why?
| | Aortic Diseases | 1 | 2017 | 108 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 827 | 0.130 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 5 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3118 | 0.130 |
Why?
| | Rats | 1 | 2023 | 4973 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2017 | 257 | 0.120 |
Why?
| | Oxygen Consumption | 1 | 2017 | 588 | 0.120 |
Why?
| | Adhesiveness | 1 | 2014 | 19 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 361 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2017 | 2799 | 0.120 |
Why?
| | Contrast Media | 1 | 2017 | 369 | 0.120 |
Why?
| | Aorta | 1 | 2017 | 389 | 0.120 |
Why?
| | Child, Preschool | 5 | 2021 | 9093 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4718 | 0.110 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 20 | 0.110 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2551 | 0.110 |
Why?
| | Adolescent | 7 | 2021 | 17864 | 0.110 |
Why?
| | Compliance | 1 | 2013 | 46 | 0.110 |
Why?
| | Retrospective Studies | 5 | 2021 | 12547 | 0.110 |
Why?
| | Blood Circulation | 1 | 2013 | 34 | 0.110 |
Why?
| | Bioengineering | 1 | 2013 | 13 | 0.110 |
Why?
| | Fibroblasts | 3 | 2023 | 839 | 0.110 |
Why?
| | Solutions | 1 | 2013 | 148 | 0.110 |
Why?
| | Aneurysm, Ruptured | 1 | 2013 | 34 | 0.110 |
Why?
| | Aneurysm | 1 | 2013 | 29 | 0.110 |
Why?
| | Epithelium | 1 | 2013 | 297 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1321 | 0.100 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2013 | 114 | 0.100 |
Why?
| | Pressure | 1 | 2013 | 219 | 0.100 |
Why?
| | Surface Properties | 1 | 2013 | 387 | 0.100 |
Why?
| | Swine | 1 | 2014 | 704 | 0.100 |
Why?
| | Vagina | 1 | 2013 | 145 | 0.100 |
Why?
| | Time Factors | 5 | 2021 | 6141 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2019 | 3015 | 0.090 |
Why?
| | Heart Failure | 1 | 2023 | 1962 | 0.090 |
Why?
| | Skin | 1 | 2014 | 659 | 0.090 |
Why?
| | Precision Medicine | 1 | 2013 | 340 | 0.080 |
Why?
| | Middle Aged | 6 | 2022 | 26827 | 0.080 |
Why?
| | Signal Transduction | 1 | 2021 | 4525 | 0.080 |
Why?
| | Disease Progression | 1 | 2015 | 2389 | 0.080 |
Why?
| | Endothelial Cells | 2 | 2023 | 685 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4420 | 0.070 |
Why?
| | Elasticity | 2 | 2019 | 190 | 0.070 |
Why?
| | Proteomics | 2 | 2023 | 844 | 0.070 |
Why?
| | Infant | 4 | 2021 | 7946 | 0.070 |
Why?
| | Age Factors | 3 | 2019 | 2894 | 0.070 |
Why?
| | Myocardium | 2 | 2021 | 922 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 4904 | 0.060 |
Why?
| | Amyloidogenic Proteins | 1 | 2023 | 9 | 0.060 |
Why?
| | tau Proteins | 1 | 2023 | 65 | 0.050 |
Why?
| | Young Adult | 4 | 2019 | 10498 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 97 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 249 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 349 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 190 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 189 | 0.050 |
Why?
| | Aged | 4 | 2022 | 19119 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 272 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 458 | 0.050 |
Why?
| | Cattle | 1 | 2023 | 924 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 387 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2023 | 668 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2020 | 213 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3334 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 130 | 0.040 |
Why?
| | Genomics | 1 | 2023 | 641 | 0.040 |
Why?
| | Numerical Analysis, Computer-Assisted | 1 | 2018 | 17 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 20 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 66 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 82 | 0.040 |
Why?
| | Rheology | 1 | 2018 | 86 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2018 | 61 | 0.040 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 137 | 0.040 |
Why?
| | Aftercare | 1 | 2019 | 186 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 387 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 56 | 0.040 |
Why?
| | Shear Strength | 1 | 2017 | 65 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 267 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 575 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 983 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 208 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2023 | 3896 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 1843 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 776 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 748 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 2815 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1267 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1229 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 275 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 675 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 447 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 313 | 0.030 |
Why?
| | Risk Factors | 2 | 2017 | 8642 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1646 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2013 | 47 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2015 | 746 | 0.030 |
Why?
| | Angiography | 1 | 2013 | 177 | 0.030 |
Why?
| | Inflammation | 1 | 2022 | 2485 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 198 | 0.020 |
Why?
| | Adult | 2 | 2023 | 30656 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2341 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1558 | 0.020 |
Why?
| | Risk Assessment | 1 | 2013 | 2976 | 0.010 |
Why?
|
|
Kheyfets's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|